Cigna will stop covering GLP-1 weight-loss drugs such as Wegovy and Zepbound for its employees starting July 1, signaling that even major healthcare companies are struggling with the high cost of these medications
During the tapering phase, monitor your appetite changes, weight fluctuations, and mood daily, as this data helps you and your provider adjust the pace if needed
25, 2024 The Lancet, Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression, March 2026 UCHealth, Many people using GLP-1 weight loss drugs may not be eating enough nutritious food, May 19, 2025 UCLA Health, Rapid weight loss can lead to loss of muscle mass, May 1, 2024 University of Colorado, The Underappreciated Benefits of GLP-1 Receptor Agonists, Nov
You will push the excess back once bubbles are cleared
Observe patients carefully for signs and symptoms of pancreatitis (persistent severe abdominal pain, sometimes radiating to the back with or without vomiting)
Who gets coverage
